| 预期应用     ELISA法定量测定人血清、血浆、唾液、细胞培养物上清或其它相关液体中MMP-9含量。   概述     MMP-9基因位于染色体20q11.1~13.1,26~27kbp,具有13个外显子和9个内含子。哺乳类动物MMP-9mRNA的同源性约为80%。MMP-9的启动子区内含有活化蛋白(AP)-1、AP-2和刺激蛋白(SP)-1因子结合位点,人的MMP-9启动子区还有核因子(NF)κB、ETS结合位点和转化生长因子(TGF)-β抑制元件MMPs主要由3个独特的、保守的结构域构成,包括前肽区(氨基末端区)、催化区和羧基末端区(类血红素结合蛋白酶区)。MMP-9是明胶酶中的一种,除了有MMPs的原型结构外,MMP-9的催化区还包括3个重复的型纤维连接蛋白结构域,这个结构域与明胶或弹性蛋白有高度的亲和力。MMP-9包含一个V型的胶原蛋白结构域,这个结构域有高度的糖基化作用,,它影响底物的特异性以及有抗衰变的作用。MMP-9有许多作用底物,如Ⅳ、Ⅴ、Ⅶ、Ⅹ、Ⅺ型胶原、蛋白聚糖的核心蛋白、明胶、纤维粘连蛋白、层粘连蛋白、弹性蛋白等,细胞因子及其受体也是MMP-9作用的底物。   实验原理     本试剂盒应用双抗体夹心酶标免疫分析法测定标本中MMP-9水平。用纯化的抗体包被微孔板,制成固相抗体,往包被单抗的微孔中依次加入MMP-9抗原、生物素化的抗人MMP-9抗体、HRP标记的亲和素,经过彻底洗涤后用底物TMB显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的MMP-9呈正相关。用酶标仪在450nm波长下测定吸光度(OD值),计算样品浓度。   Intended use     This immunoassay kit allows for the specific measurement of total human active and pro-Matrix Metalloproteinase 9 (total MMP-9) concentrations in cell culture supernates, serum, and plasma.   Introduction      Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade extracellular matrix proteins. They are secreted as zymogens (pro-MMPs) that are activated by a variety of proteinases or by reaction with organic mercurials. They are inhibited by specific tissue inhibitors of metalloproteinases (TIMPs) and by α2-macroglobulin. The regulation of MMP activity is important in tissue remodeling, inflammation, tumor growth and metastasis.     Human MMP-9 (also known as gelatinase B) is secreted as a 92 kDa zymogen. Cleavage of pro-MMP-9 at or near residue 87 results in the active enzyme with a mass of approximately 82 kDa. MMP-9 has three fibronectin type II domains, a hemopexin-like domain and a proline-rich type V collagen-homologous domain. Pro-MMP-9 can be activated by MMP-3 or by certain bacterial proteinases. MMP-9 is inhibited byα2-macroglobulin or by TIMP-1, which binds to pro-MMP-9 as well as to active MMP-9.     Pro-MMP-9 is secreted by monocytes, macrophages, neutrophils, keratinocytes, fibroblasts, osteoclasts, chondrocytes, skeletal muscle satellite cells, endothelial cells, and various tumor cells. Pro-MMP-9 expression is upregulated by TGF-β1, IL-1β, TGF-α, PDGF-AB, TNF-α and IL-1α. Substrates for MMP-9 include denatured collagen type I (gelatin), native collagens type IV, V, VII, X and XI, fibrinogen, vitronectin, IL-1β and entactin, a molecule that bridges laminin and type IV collagen.     MMP-9 is involved in inflammation, tissue remodeling, wound healing, mobilization of matrix-bound growth factors and processing of cytokines. Its expression correlates with the  desmoplasia (abnormal collagen deposition) that accompanies pancreatic cancer, with the  metastasis to lymph nodes by humanbreast carcinoma cells and with the invasion of regional  vessels in giant cell tumors of bones. MMP-9 may be elevated in gingival crevicular fluid and saliva in patients with gingivitis and periodontal diseases.   |